Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                FDA Meetings, Conferences and Workshops

FDA Meetings, Conferences and Workshops

                        FDA Meetings, Conferences, and Workshops: Past Events
          FDA Annual Reports on Conferences


                        Public Calendar - Meetings With FDA Officials Home
          News & Events
          FDA Meetings, Conferences and Workshops
          FDA Oncology Center of Excellence Presents: Conversations on Cancer: Transforming Patient Lives by Therapeutic and Regulatory Innovations - 02/01/2024FDA Meetings, Conferences and Workshops Webcast
    Event Title
              FDA Oncology Center of Excellence Presents: Conversations on Cancer: Transforming Patient Lives by Therapeutic and Regulatory Innovations


                  February 1, 2024

  

    
  Share
    Post
    Linkedin

    Email
    PrintOn This Page
      Meeting InformationDate:
          
  


     
           

February 1, 2024   

 
 
        
                                      Time: 
                                      
9:30 AM
    - 11:00 AM
ET
                
  Organized By: 
      Organizer
          Oncology Center of Excellence
            
              Sponsored By: 
        Sponsor
          Food and Drug Administration

 

     Attend
    Register for This Event
  Image
              Conversations on Cancer: Transforming Patient Lives by Therapeutic and Regulatory Innovations - GraphicTwitter: #ConversationsOnCancer

Background:

The Conversation on Cancer, in recognition of World Cancer Day, is the second collaboration between FDA Oncology Center of Excellence (OCE) and the European Medicines Agency (EMA) in this public panel discussion series. The conversation will focus on the introduction of certain innovative therapeutic classes in the past two decades that have revolutionized the care for patients with chronic myeloid leukemia, multiple myeloma, and melanoma.  The discussion will provide an overview of regulatory programs that expedite access to patients, including FDA’s Breakthrough therapy designation and Accelerated Approval; and EMA’s Prime and Conditional Approval. The panel of patients, investigators and regulators aims to highlight successes from development to approval.  We’ll specifically outline:

Patient experiences with new innovative therapeutic classes
	Investigator approaches in development.
	Role of regulatory collaboration and programs to expedite development and approval of novel, safe, and effective therapeutics.Webcast Information:

A free-of-charge webcast of this public panel discussion will be provided. Registration for the webcast is required at the link above.

FDA plans to post archived webcast of this Conversations on Cancer program at: https://www.fda.gov/about-fda/project-community/conversations-cancer

Contact:

For any inquiries regarding this program, please send an email to: OCE-Engagement@fda.hhs.gov

                                                                                  Content current as of:
      01/11/2024More Meetings,
      Conferences, and
      Workshops
        
        FDA Meetings, Conferences and Workshops

          
                        FDA Meetings, Conferences, and Workshops: Past Events
          FDA Annual Reports on Conferences


                        Public Calendar - Meetings With FDA Officials
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop